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4. Introduction 
Aflatoxin B, is the most potent liver carcinogen 
known for the rat [ 1 ] and is toxic for a wide species 
range [2]. This has led to the suggestion that this 
compound does not require metabolic activation to 
induce qancer, it being carcinogenic per se. There is, 
however, a considerable body of evidence, such as 
organ specificity [3], the effect of hypophysectomy 
[4] , binding of 3 H-labelled material to -cellular macro- 
molecules [.5] and species differences [2], to indicate 
that metabolic activation is a necessary prerequisite 
for tumour initiation. Furthermore, it is now thought 
that most chemical carcinogens are reactive electro- 
philic molecules or must be metabolically converted 
to such before they can induce cancer [6]. Aflatoxin 
B, does not fit this criterion of extreme reactivity, it 
only showing a weak association with DNA [7,8] . 
A number of metabolites of aflatoxin B, have 
been identified [9-l l] , but none of these are as ac- 
tive as the parent compound in various biological 
tests for measuring aflatoxin B, toxicity [ 12-141. 
Previous work has provided evidence for a new liver 
microsomal metabolite of aflatoxin B, which is both 
toxic and mutagenic to bacteria [ 15,161 and which 
reacts covalently with nucleic acids and protein [ 171. 
It was proposed on the basis of structure-activity 
relationships [ 151 that this metabolite may be 2,3- 
epoxyaflatoxin B 1 ; a possible ultimate carcinogenic 
form of this compound. This report provides strong 
evidence for the formation of such an intermediate. 
2. Materials and methods 
Six replicate flasks, each containing hamster liver 
microsomes equivalent to 500 mg of fresh liver, 0.7 
moles aflatoxin B, and the necessary cofactors, 
were incubated together at 37’C for 60 min as pre- 
viously described [ 171. At the end of the incubation 
period, flasks’ contents were combined and the mi- 
crosomes removed by ultracentrifugation at 100 000 
g (av) for 45 min. The supernatant liquid was decant- 
ed and extracted 3 times with an equal volume of 
CHC 13. After solvent extraction the aqueous layer 
was freeze-dried, the residue redissolved in methanol 
and purified by preparative thin layer chromatogra- 
phy on 2 mm silica gel layers in CHC 1 3 methanol 
(70 : 30). The two main fluorescent bands with Rf 
values 0.58 and 0.32 were removed and eluted with 
methanol. 
2,3-Dihydrodiolaflatoxin B, was prepared as 
follows: 10 mg aflatoxin B, were reacted for 72 hr 
at room temperature with a 5 M excess of m-chloro- 
perbenzoic acid in dichloromethane. The reaction 
mixture was purified by preparative thin layer chroma- 
tography in CHC13/methanol(97 :3) and the main 
fluorescent band removed (Rf = 0.45, Rf aflatoxin 
B, = 0.85) and eluted with methanol. Mass spectrum 
m/e = 484 and 486 (m’) (3 : 1 ratio of peak heights, 
indicating the presence of the two chlorine isotopes), 
328 (m’ -ClC,H,COO-). Infa-red spectrum (KBr) 
showed a similar spectrum to aflatoxin B1 but with 
new bands at 3400 (-OH), 1732 (chlorobenzoic 
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Fig. 1. Enzymatic or chemical reaction sequence for production of the two water-soluble aflatoxin Bt derivatives. 
ester) and 1670 cm- 1 (phenyl ketone). Ultraviolet 
spectrum in methanol showed absorption bands at 
265 and 367 nm. On additon of alkali the 367 nm 
band was lost and a new band at 403 nm appeared 
while the 265 nm absorption moved up to 288 nm. 
These spectral shifts were reversible on neutralisation. 
On the basis of these physical characteristics and be- 
cause m-chloroperbenzoic acid will only attack olefi- 
nit double bonds, the reaction product was assigned 
structure II (fig. 1). On hydrolysis of II at O’C with 
1 M equivalent of methanolic KOH, there was a slow 
conversion of II to a new compound which had a 
much lower Rf value on thin layer chromatography 
in CHC 13 /methanol (97 : 3). After purification by 
preparative thin layer chromatography in this solvent 
system this new product was found to have an identi- 
cal ultraviolet absorption spectrum to a sample of 
aflatoxin B,, prepared by the method of Pohland 
et al. [ 181 in methanol and alkaline methanol. How- 
ever the compound was more polar than aflatoxin 
B2,(Rf in CHC13/methanol (97 : 3) = 0.06; afla- 
toxin B za=0.15; aflatoxin B,= 0.65). The structure 
of this compound was adjudged to be that of III, 
2,3-dihydrodiolaflatoxin B, . 
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3. Results and discussion 
The 2,3-double bond of aflatoxin Bl is olefinic 
in character and is therefore susceptible to peracid 
attack. During attempts to synthesize the 2,3-epox- 
ide of aflatoxin B1 using m-chloroperbenzoic acid 
it was noticed that one of the reaction products al- 
ways predominated with varying molar proportions 
of acid to aflatoxin, different reaction temperatures 
or the presence or absence of buffer. On the basis of 
the physical data set out in Materials and methods, 
structure II was assigned to this product, which could 
only have been formed by initial formation of 2,3- 
epoxyaflatoxin B, and subsequent attack by m-chlor- 
obenzoic acid, as set out in fig. 1. The difficulties in 
epoxidising vinyl ethers are discussed in ref. [ 191. 
If during the metabolism of aflatoxin B1 by liver 
microsomes, a reactive epoxide is formed, one would 
expect some conversion of this metabolite by hydrol- 
ysis to a dihydrodiol. An analogous process has been 
demonstrated for some epoxides of carcinogenic 
polycyclic hydrocarbons [20]. 2,3-Dihydrodiolafla- 
toxin B, (III) was prepared chemically by alkaline 
hydrolysis of II and its thin layer properties compared 
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Table 1 
Thin layer and spectral properties of the two water-soluble 
metabolites of aflatoxin B1. 
Metabolite Rf value Maximum absorption 
(nm) 
A B C* 
1 0.00 0.58 0.65 402 
2 0.00 0.32 0.54 407 
Esterified 1 0.65 
Esterified 2 0.24 
Scilvents, A = CHC13/methanol(97 : 3); B = CHC13/methanol 
(70 : 30); C = ethyl acetate/methyl ethyl ketone/formic acid/ 
water (5 : 3 : 1 : 1). 
with the fluorescent CHCl, extractable metabolites 
obtained after a large scale incubation of aflatoxin 
B, with hamster liver microsomes. Microsomes from 
this species were used because they have high activity 
in converting aflatoxin B1 to a reactive form [ 151. No 
equivalent material to the dihydrodiol could be found 
after aflatoxin B, metabolism. However, it was no- 
ticed during studies on the metabolism of 14C-ring 
labelled aflatoxin Bl by hamster liver microsomes 
(R.C. Gamer, unpublished) that considerable amounts 
of radioactivity were not CHC13-extractable from 
the aqueous incubation medium. On examining the 
aqueous layer from the large scale incubation of afla- 
toxin B, , after solvent extraction, some blue fluore- 
scent metabolites were found which remained at the 
origin in the standard thin layer chromatographic 
procedures for separation of aflatoxin Bl metabolites 
(table 1). 
These water-soluble metabolites were considerably 
more polar than the dihydrodiol and any other known 
metabolites of aflatoxin Bl , and might have been 
formed by further metabolism of the dihydrodiol. 
This was tested by incubating 100 pg of dihydrodiol 
with 500 mg fresh liver equivalents of hamster liver 
microsomes for 60 min at 37’C and extracting any 
metabolites formed as described in the Materials and 
methods. Two water-soluble blue fluorescent products 
were obtained which had identical thin layer and spec- 
tral properties to the two water-soluble metabolites 
found after the large scale incubation of aflatoxin B, 
(table 1). The conversion of the dihydrodiol to these 
two products was non-enzymatic, since they were ob- 
tained even if microsomes were omitted from the 
incubation medium. Acetyl esters of the two water- 
soluble aflatoxin B, metabolites, obtained by acetic 
anhydride esterification had identical thin layer prop- 
erties to the acetyl esters of the dihydrodiol degrada- 
tion products. 
Although these two water-soluble products have 
as yet not been characterised, because of insufficient 
material, the fact that they show identical physical 
characteristics in the properties tested, suggests that 
the two dihydrodiol degradation products are identi- 
cal to the two water-soluble aflatoxin B1metabolites. 
This indicates that during the metabolism of aflatoxin 
by hamster liver microsomes there may be some con- 
version to the 2,3-epoxide some of which then un- 
dergoes hydrolysis to the dihydrodiol and further 
conversion to the two water-soluble products (see 
fig. 1). 
Evidence has thus been provided for the probable 
formation of 2,3-epoxyaflatoxin Bl as an interme- 
diate during aflatoxin B, metabolism by hamster 
liver microsomes. It is likely that it is this metabolite 
which is lethal and mutagenic to bacteria [15,16], 
reacts with nucleic acids [17] and is the ultimate 
carcinogenic form of this compound. Species differ- 
ences in sensitivity to aflatoxin B, carcinogenicity 
may well be related to the balance between metabo- 
lism via the epoxide pathway and metabolism through 
the other known pathway i.e. activation versus de- 
toxification. 
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